Sueldos y Compensación en Day One Biopharmaceuticals

Day One Biopharmaceuticals is a profoundly innovative, fiercely dedicated clinical-stage company absolutely revolutionizing targeted therapies for genetically defined pediatric cancers. They brilliantly develop incredibly advanced, highly brain-penetrant inhibitors—including their absolute breakthrough candidate DAY101—fiercely aiming to completely transform incredibly critical survival outcomes for deeply vulnerable children battling severe relapsed low-grade gliomas.